Pyxus (PYYX) awards 10,980 RSUs to company director

Q: What insider transaction did Pyxus International (PYYX) report on this Form 4?

The filing reports that a director of Pyxus International, Inc. received an award of 10,980 restricted stock units , each representing a contingent right to one share of Pyxus common stock.

Q: How many restricted stock units were granted to the Pyxus (PYYX) director?

The director was granted 10,980 restricted stock units , as disclosed in the derivative securities table.

Q: When were the Pyxus (PYYX) restricted stock units granted and when can they vest?

The RSUs were awarded on November 20, 2025 . They are to be earned for vesting based on continued service as a director through the earlier of August 14, 2026 or the start of the 2026 annual shareholders meeting, with prorated vesting if service ends sooner.

Q: What additional conditions affect vesting of the Pyxus (PYYX) director RSUs?

Vesting is further contingent on the earliest of: March 31, 2031 ; a defined Change in Control involving a merger, consolidation, share exchange or asset sale; or Pyxus common stock becoming listed for trading on a registered or approved securities exchange.

Q: Is this Pyxus (PYYX) Form 4 filed for one reporting person or a group?

The Form 4 indicates that it is filed by one reporting person , not by more than one reporting person.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Pyxus International, Inc. reported an equity grant to one of its directors in the form of 10,980 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Pyxus common stock at a future date.

The RSUs were awarded on November 20, 2025 and are to be earned for vesting based on continued board service through the earlier of August 14, 2026 or the start of the 2026 annual shareholders meeting, with prorated vesting if service ends earlier. Vesting is further contingent on the earliest of March 31, 2031, a defined change in control transaction, or the company’s common stock becoming listed on a registered or approved securities exchange.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider GEORGE ROBERT DAVID

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	10,980	$0.00	--

Holdings After Transaction: Restricted Stock Units — 10,980 shares (Direct)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of Pyxus International, Inc. common stock. The restricted stock units were awarded on November 20, 2025 to be earned for vesting based on continued service as a director through the earlier of August 14, 2026 or the commencement of the Pyxus International, Inc. annual shareholders meeting to be held in 2026, with a prorated amount being earned for vesting if service ceases before such date, and with vesting being further contingent upon the earliest to occur of the following: (i) March 31, 2031; (ii) the occurrence of a 'Change in Control' (as defined in the Pyxus International, Inc. Amended and Restated 2020 Incentive Plan) as a result of a merger, consolidation, share exchange or sale of all or substantially all of the assets of the Company; or (iii) Pyxus International, Inc.'s common stock being listed for trading on a securities exchange registered with the SEC under Section 6 of the Securities Exchange Act of 1934 or an approved foreign securities exchange.

Form 4 Insider Transactions: What Each Field Means →

11/21/2025 - 08:31 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GEORGE ROBERT DAVID

(Last)

(First)

(Middle)

6001 HOSPITALITY COURT

SUITE 100

(Street)

MORRISVILLE

27560

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PYXUS INTERNATIONAL, INC. [ PYYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	11/20/2025		A		10,980		⁽²⁾	03/31/2031	Common Stock	10,980	$0	10,980	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Pyxus International, Inc. common stock.

2. The restricted stock units were awarded on November 20, 2025 to be earned for vesting based on continued service as a director through the earlier of August 14, 2026 or the commencement of the Pyxus International, Inc. annual shareholders meeting to be held in 2026, with a prorated amount being earned for vesting if service ceases before such date, and with vesting being further contingent upon the earliest to occur of the following: (i) March 31, 2031; (ii) the occurrence of a 'Change in Control' (as defined in the Pyxus International, Inc. Amended and Restated 2020 Incentive Plan) as a result of a merger, consolidation, share exchange or sale of all or substantially all of the assets of the Company; or (iii) Pyxus International, Inc.'s common stock being listed for trading on a securities exchange registered with the SEC under Section 6 of the Securities Exchange Act of 1934 or an approved foreign securities exchange.

Remarks:

	/s/ Christopher G. Meredith, Attorney-In-Fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Pyxus International (PYYX) report on this Form 4?

The filing reports that a director of Pyxus International, Inc. received an award of 10,980 restricted stock units, each representing a contingent right to one share of Pyxus common stock.

How many restricted stock units were granted to the Pyxus (PYYX) director?

The director was granted 10,980 restricted stock units, as disclosed in the derivative securities table.

When were the Pyxus (PYYX) restricted stock units granted and when can they vest?

The RSUs were awarded on November 20, 2025. They are to be earned for vesting based on continued service as a director through the earlier of August 14, 2026 or the start of the 2026 annual shareholders meeting, with prorated vesting if service ends sooner.

What additional conditions affect vesting of the Pyxus (PYYX) director RSUs?

Vesting is further contingent on the earliest of: March 31, 2031; a defined Change in Control involving a merger, consolidation, share exchange or asset sale; or Pyxus common stock becoming listed for trading on a registered or approved securities exchange.

What does each restricted stock unit granted by Pyxus (PYYX) represent?

Each restricted stock unit represents a contingent right to receive one share of Pyxus International, Inc. common stock, subject to the vesting and contingency conditions described.

Is this Pyxus (PYYX) Form 4 filed for one reporting person or a group?

The Form 4 indicates that it is filed by one reporting person, not by more than one reporting person.